BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Shanghai ChemPartner Co., Ltd. and Sanwa Kagaku Kenkyusho., Ltd. (SKK) Announce Strategic Alliance


4/20/2009 10:45:36 AM

TOKYO, April 20 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., Ltd., (ChemPartner) a group company of ShangPharma, and Sanwa Kagaku Kenkyusho Co., Ltd. (SKK), a pharmaceutical company headquartered in Nagoya, Japan, today announced that they have entered into a strategic alliance. The partnership was formed as a key element of a strategic initiative for SKK to target the Asian market, in step with SKK's new medium-long term business plan and expanding presence in diabetic research and will help SKK to achieve its drug discovery goals.

Commenting on this alliance, Michael Hui, CEO of ChemPartner said, "We are delighted to be entering this strategic alliance with SKK. We are proud and honoured that SKK have selected ChemPartner to be one of their partners and we look forward to building a long and successful relationship between our two companies in the future." The business terms and details of this project were not disclosed.

About Sanwa Kagaku Kenkyusho Co. Ltd.

SKK, a subsidiary of SUZUKEN, one of the leading pharmaceutical wholesaler in Japan, is a fully-integrated pharmaceutical company headquartered in Nagoya, Japan with established therapeutic and diagnostic products focusing on diabetes, cardiovascular and inflammation. SKK has an annual turnover of 60 billion yen and employs over 1,500 personnel. SKK's mission is to provide a 'New Value' to those who wish a healthy life, especially in the diabetes and diabetes-related therapeutic areas.

Further information is available at http://www.skk-net.com/eng/ .

About Shanghai ChemPartner

Founded in 2003, Shanghai ChemPartner Company Ltd. (ChemPartner) has become one of the leading global contract research organizations providing chemistry, biology, pharmacology, DMPK, process R&D, analytical development, pre-formulation and contract manufacturing services to pharmaceutical and biotech companies around the world.

ChemPartner currently has a staff of 1000 scientists. Our key scientific leadership team has gained experience in the top pharmaceutical and biotech R&D organizations in the U.S., Canada, and Japan, as well as in many European countries and top R&D organizations in China.

CONTACT: Jasmine Luo, +86-21-51370655, ynluo@chemexplorer.com.cn

Web site: http://www.chempartner.cn/
http://www.skk-net.com/eng/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES